Your browser is no longer supported. Please, upgrade your browser.
Settings
PETX Aratana Therapeutics, Inc. daily Stock Chart
PETX [NASD]
Aratana Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own2.50% Shs Outstand49.90M Perf Week-2.07%
Market Cap236.53M Forward P/E46.93 EPS next Y0.10 Insider Trans-3.80% Shs Float47.42M Perf Month-2.47%
Income-13.00M PEG- EPS next Q-0.10 Inst Own65.30% Short Float1.23% Perf Quarter24.41%
Sales38.70M P/S6.11 EPS this Y73.10% Inst Trans-4.86% Short Ratio0.63 Perf Half Y-23.42%
Book/sh1.99 P/B2.38 EPS next Y126.30% ROA-10.80% Target Price4.92 Perf Year-4.24%
Cash/sh0.74 P/C6.38 EPS next 5Y15.00% ROE-13.00% 52W Range3.30 - 7.16 Perf YTD-22.68%
Dividend- P/FCF- EPS past 5Y0.60% ROI- 52W High-33.80% Beta1.37
Dividend %- Quick Ratio5.30 Sales past 5Y210.30% Gross Margin67.70% 52W Low43.64% ATR0.11
Employees79 Current Ratio6.70 Sales Q/Q85.00% Oper. Margin-28.30% RSI (14)56.05 Volatility2.17% 2.12%
OptionableYes Debt/Eq0.00 EPS Q/Q26.30% Profit Margin-33.50% Rel Volume0.34 Prev Close4.78
ShortableYes LT Debt/Eq0.00 EarningsMay 08 AMC Payout- Avg Volume924.33K Price4.74
Recom3.00 SMA20-1.20% SMA506.71% SMA200-5.91% Volume316,794 Change-0.84%
Apr-30-19Downgrade Credit Suisse Outperform → Neutral
Jan-24-19Downgrade William Blair Outperform → Mkt Perform
Jan-11-19Downgrade Stifel Buy → Hold
Aug-06-18Reiterated Stifel Buy $8 → $7
Mar-27-18Upgrade Stifel Hold → Buy $8
Mar-12-18Upgrade CL King Neutral → Buy
Dec-27-17Initiated CL King Neutral
Nov-17-17Initiated H.C. Wainwright Buy $10
Aug-25-17Reiterated Lake Street Buy $15 → $10
May-10-17Reiterated Stifel Buy $8 → $7
Sep-06-16Resumed Lake Street Buy $15
Aug-19-16Resumed Jefferies Buy
Mar-16-16Reiterated Stifel Buy $12 → $11
Feb-04-16Initiated Credit Suisse Outperform
Nov-30-15Reiterated Barclays Overweight $30 → $15
Sep-25-15Downgrade Craig Hallum Buy → Hold
Jul-29-15Initiated Lake Street Buy $28
Feb-25-15Reiterated Stifel Buy $19 → $23
May-14-14Reiterated Stifel Buy $30 → $22
Feb-10-14Initiated Barclays Overweight $30
Jun-12-19 07:34AM  The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana Benzinga
Jun-11-19 04:05PM  Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial PR Newswire
Jun-07-19 04:59PM  Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders PR Newswire
03:37PM  AMBR, PETX Shareholder Class Actions: Halper Sadeh LLP Announces Shareholder Class Action Lawsuits Against Amber Road, Inc. and Aratana Therapeutics, Inc. AMBR, PETX GlobeNewswire
Jun-06-19 03:20PM  Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc. GlobeNewswire
02:35PM  PETX, ADSW, AQ Shareholder Alert: Halper Sadeh LLP Reminds Investors of Class Action Lawsuits Filed Against Aratana Therapeutics, Inc., Advanced Disposal Services, Inc., and Aquantia Corp. PETX, ADSW, AQ GlobeNewswire
Jun-03-19 03:46PM  Behind the scenes on Aratanas sale to Elanco American City Business Journals
May-13-19 05:19PM  Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype Imaging Holdings, Inc., PetIQ, Inc., and Pinduoduo, Inc. PR Newswire
May-11-19 01:11PM  INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Merger ACCESSWIRE
May-09-19 02:22PM  PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers GlobeNewswire
May-08-19 06:45PM  Aratana (PETX) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:33PM  Aratana: 1Q Earnings Snapshot Associated Press
04:05PM  Aratana Therapeutics Reports First Quarter 2019 Financial Results PR Newswire
May-07-19 08:00AM  Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference PR Newswire
May-06-19 04:06PM  SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc PETX ACCESSWIRE
May-03-19 08:57PM  INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Buyout PR Newswire
06:35PM  SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc PETX ACCESSWIRE
05:39PM  ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX Business Wire
May-02-19 10:45AM  MERGER ALERT - PETX, BRSS and KEYW: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
May-01-19 10:32AM  Aratana (PETX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-30-19 02:17PM  PETX, WP, and EFII SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts GlobeNewswire
12:21PM  MERGER ALERT PETX and SRMC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
Apr-29-19 05:28PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm GlobeNewswire
01:00PM  QTNA, PETX, and SFS SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers GlobeNewswire
10:19AM  QTNA, PETX, SFS Shareholder Alert: Halper Sadeh LLP Reminds Investors it is Investigating Whether the Sale of These Companies is Fair to Shareholders QTNA, PETX, SFS GlobeNewswire
10:10AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Aratana Therapeutics, Inc. to Elanco Animal Health Incorporated is Fair to Shareholders GlobeNewswire
Apr-26-19 08:25PM  ARATANA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger GlobeNewswire +39.65%
05:37PM  Aratana (PETX) Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Aratana Therapeutics, Inc. is Fair to Shareholders PETX GlobeNewswire
02:25PM  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. PR Newswire
12:33PM  Elanco Animal Health Announces $245M Stock-For-Stock Acquisition Of Aratana Therapeutics Benzinga
09:43AM  News Surrounds 3 Small Biotechs, With a Merger Claiming One TheStreet.com
08:43AM  Aratana Therapeutics will sell for $245M to big animal health player American City Business Journals
07:55AM  Animal health giant Elanco to acquire Aratana Therapeutics MarketWatch
06:29AM  Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus Business Wire
06:28AM  Aratana Therapeutics to be Acquired by Elanco Animal Health PR Newswire
Apr-22-19 08:30AM  Aratana Therapeutics to Report First Quarter 2019 Financial Results PR Newswire
Apr-04-19 12:46PM  Easy Come, Easy Go: How Aratana Therapeutics (NASDAQ:PETX) Shareholders Got Unlucky And Saw 77% Of Their Cash Evaporate Simply Wall St.
Apr-01-19 07:25AM  Research Report Identifies Diamondrock Hospitality, Essex Property Trust, Tenet Healthcare, ARMOUR Residential REIT, Mack-Cali Realty, and Aratana Therapeutics with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-21-19 06:30AM  HLS Therapeutics Announces Q4 and Year-End 2018 Financial Results CNW Group
Mar-18-19 12:07PM  Edited Transcript of PETX earnings conference call or presentation 12-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-13-19 11:48PM  Aratana Therapeutics Inc (PETX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
12:07PM  CEO: Aratana is focused on 'near-term value enhancement,' but R&D will continue American City Business Journals
Mar-12-19 08:10PM  Aratana Therapeutics Inc (PETX) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:45PM  Aratana (PETX) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:51PM  Aratana: 4Q Earnings Snapshot Associated Press
04:05PM  Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results PR Newswire
02:30PM  Aratana Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Feb-25-19 09:25AM  Aratana Therapeutics, Inc. (NASDAQ:PETX): Are Analysts Optimistic? Simply Wall St.
Feb-13-19 08:30AM  Aratana Therapeutics to Participate at Upcoming Investment Conferences PR Newswire
Feb-12-19 08:30AM  Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results PR Newswire
Feb-04-19 07:45AM  Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer PR Newswire
Jan-25-19 07:35AM  Factors of Influence in 2019, Key Indicators and Opportunity within Immunomedics, Diamondrock Hospitality, Chatham Lodging Trust (REIT), Essex Property Trust, Del Taco Restaurants, and Aratana Therapeutics New Research Emphasizes Economic Growth GlobeNewswire
07:12AM  Aratana Therapeutics Sees Hammer Chart Pattern: Time to Buy? Zacks
Jan-22-19 08:40AM  Aratana Therapeutics (PETX) in Focus: Stock Moves 6.8% Higher Zacks
Jan-18-19 03:47PM  St. Peter's exit from Aratana ends detour from investing to running a company American City Business Journals +6.76%
11:02AM  Does Aratana Therapeutics, Inc.s (NASDAQ:PETX) CEO Pay Compare Well With Peers? Simply Wall St.
07:49AM  The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug Benzinga
Jan-17-19 11:10PM  Aratana Therapeutics CEO and founder resigns American City Business Journals
08:53PM  Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer PR Newswire
Jan-11-19 03:11PM  Aratana Therapeutics COO retires; key investor shrinks stake American City Business Journals -26.55%
11:10AM  Why Aratana Therapeutics Inc. Is Tumbling Today Motley Fool
Dec-31-18 09:01AM  Aratana Therapeutics pays off a big loan American City Business Journals
Dec-23-18 11:36AM  Do Hedge Funds Love Aratana Therapeutics Inc (PETX)? Insider Monkey
Dec-12-18 12:22AM  Edited Transcript of PETX earnings conference call or presentation 2-Nov-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-21-18 02:00PM  Do Directors Own Aratana Therapeutics Inc (NASDAQ:PETX) Shares? Simply Wall St.
Nov-09-18 09:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within EnLink Midstream, Kemper, Aratana Therapeutics, CURO Group, Perficient, and GCP Applied Technologies New Research Emphasizes Economic Growth GlobeNewswire
Nov-01-18 07:55PM  Aratana (PETX) Tops Q3 Earnings and Revenue Estimates Zacks +6.57%
06:51PM  Aratana: 3Q Earnings Snapshot Associated Press
04:05PM  Aratana Therapeutics Reports Third Quarter 2018 Financial Results PR Newswire
Oct-26-18 10:30AM  Aratana (PETX) Q3 Earnings Preview: Here's What to Look Out For Zacks
Oct-22-18 08:47AM  Aratana Therapeutics to Report Third Quarter 2018 Financial Results PR Newswire +13.06%
Oct-11-18 08:55AM  Report: Exploring Fundamental Drivers Behind Seritage Growth Properties, Forrester Research, Chemours, MoSys, Malibu Boats, and Aratana Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-29-18 08:30AM  Aratana Therapeutics to Present at CL King and Associates Best Ideas Conference PR Newswire
Aug-24-18 04:05PM  Edited Transcript of PETX earnings conference call or presentation 3-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-15-18 03:11PM  Activist investor is buying up stock in KC's fastest-growing company American City Business Journals
Aug-07-18 08:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within GTT Communications, Hope, Black Knight, Safety Insurance Group, M.D.C., and Aratana Therapeutics New Research Emphasizes Economic Growth GlobeNewswire
Aug-03-18 06:30AM  Aratana Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 07:55PM  Aratana (PETX) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:47PM  Aratana: 2Q Earnings Snapshot Associated Press
04:05PM  Aratana Therapeutics Reports Second Quarter 2018 Financial Results PR Newswire
Jul-10-18 08:30AM  Aratana Therapeutics to Report Second Quarter 2018 Financial Results PR Newswire
Jun-26-18 01:26PM  When Will Aratana Therapeutics Inc (NASDAQ:PETX) Breakeven? Simply Wall St.
Jun-19-18 07:05AM  Breakfast Technical Briefing on Alkermes and Three Other Additional Biotech Stocks ACCESSWIRE
Jun-01-18 08:30AM  Aratana Therapeutics Files for FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) Label Expansion PR Newswire
May-22-18 04:05PM  Aratana Therapeutics to Participate at Jefferies 2018 Global Healthcare Conference PR Newswire
May-21-18 08:30AM  Aratana Therapeutics Appoints Craig Barbarosh and Lowell Robinson to its Board of Directors in Cooperation Agreement with Engaged Capital PR Newswire
May-17-18 09:00AM  Breakfast Technical Briefing on BioLine Rx and Three More Biotech Stocks ACCESSWIRE
May-08-18 10:05PM  Edited Transcript of PETX earnings conference call or presentation 4-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-05-18 12:01AM  [$$] Engaged Capital Seeks Seats on Aratana Therapeutics Board Barrons.com
May-04-18 06:15AM  Aratana Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
May-03-18 06:06PM  Aratana: 1Q Earnings Snapshot Associated Press
04:05PM  Aratana Therapeutics Reports First Quarter 2018 Financial Results PR Newswire
May-02-18 08:00AM  Recent Analysis Shows Waterstone Financial, Blue Bird, Proto Labs, American Assets Trust, MoSys, and Aratana Therapeutics Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-17-18 04:00PM  5 Drug Stocks Poised to Surpass on Earnings This Quarter InvestorPlace
Apr-12-18 08:30AM  Aratana Therapeutics to Report First Quarter 2018 Financial Results PR Newswire
Apr-05-18 09:29AM  Aratana Therapeutics Confirms Receipt of Board Nominations PR Newswire
Mar-28-18 08:39AM  Aratana Therapeutics (PETX) Soars: Stock Adds 12.4% in Session Zacks
Mar-27-18 12:10PM  Pet Therapeutic Entyce Can Drive Aratana Higher, Stifel Says In Upgrade Benzinga +12.40%
Mar-20-18 08:00AM  New Research Coverage Highlights Home, Gorman-Rupp, Aratana Therapeutics, Washington Real Estate Investment Trust, XG Technology, and Hope Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-18-18 11:20AM  Edited Transcript of PETX earnings conference call or presentation 14-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Aratana Therapeutics, Inc., a pet therapeutics company, focuses on the licensing, development, and commercialization of therapeutics for dogs and cats in the United States. Its product portfolio includes small molecule therapeutics and therapeutic candidates. The company markets NOCITA, a post-operative analgesia for cranial cruciate ligament surgery in dogs; ENTYCE for appetite stimulation in dogs; GALLIPRANT for the control of pain and inflammation associated with osteoarthritis in dogs; and canine osteosarcoma vaccine, live listeria vector for the treatment of dogs diagnosed with osteosarcoma in the United States. It is also developing NOCITA, a bupivacaine liposome injectable suspension for post-operative pain in cats; AT-002, a specific formulation of capromorelin for use in cats; AT-018, an oral CRTH2 antagonist for the treatment of atopic dermatitis in dogs; AT-006, an anti-viral eprociclovir that is used for the treatment of feline herpes virus-induced ophthalmic conditions in cats; AT-016, allogeneic adipose-derived stem cells for dogs; and AT-019, an EP4 receptor antagonist therapeutic candidate with potential in pain, inflammation, and other indications. In addition, the company develops AT-008, a therapeutic candidate for treating canine lymphoma in dogs; and other therapeutics for dogs and cats in Europe. It has collaboration agreement with Elanco Animal Health, Inc. to develop, manufacture, and commercialize GRAPIPRANT products; Pacira Pharmaceuticals, Inc. to develop and commercialization of licensed animal health products for NOCITA; and AskAt Inc for the development and commercialization of compound AT-019. Aratana Therapeutics, Inc. was founded in 2010 and is headquartered in Leawood, Kansas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AYRES JOHN CSEE REMARKSJan 30Sale4.193,12513,094129,889Feb 01 05:45 PM
St Peter StevenPRESIDENT AND CEODec 17Sale5.8546,094269,788516,626Dec 17 06:00 PM
HEINEN ERNSTChief Development OfficerNov 07Sale6.9519,308134,191135,694Nov 09 06:00 PM
HEINEN ERNSTChief Development OfficerNov 02Sale6.956924,809155,002Nov 06 06:05 PM
St Peter StevenPRESIDENT AND CEOOct 30Sale5.8611,51367,454562,720Oct 31 06:00 PM
St Peter StevenPRESIDENT AND CEOSep 21Sale6.0675,000454,305574,233Sep 21 06:31 PM
HEINEN ERNSTChief Development OfficerAug 14Sale5.151,7128,817155,694Aug 14 05:32 PM
HEINEN ERNSTChief Development OfficerAug 13Sale5.158,66044,599157,406Aug 14 05:32 PM
HEINEN ERNSTChief Development OfficerAug 10Sale5.151,95410,063166,066Aug 10 05:45 PM
HEINEN ERNSTChief Development OfficerAug 08Sale5.152,67413,771168,020Aug 10 05:45 PM
St Peter StevenPRESIDENT AND CEOJul 30Sale4.3311,51349,842649,233Jul 30 05:51 PM
Standridge BrentChief Operating OfficerJun 25Sale4.5610,00045,64499,967Jun 27 05:32 PM